McKesson Corporation
Thesis
McKesson is a drug distributor with a strong market position, holding over 92% market share alongside two other large players. The company is expected to benefit from growth in healthcare information technology and has a significant amount of cash that can be deployed for further growth or stock repurchases, making it a compelling investment opportunity.
Did it work?
The stock pitch for McKesson was highly successful, with an extraordinary return of +8254.6%. The thesis highlighted the company's strong market position and potential for growth, both of which have clearly materialized given the substantial price increase. This performance aligns well with the long investment thesis, indicating that the anticipated benefits from market dynamics and cash deployment have played out effectively.
Raw excerpt
No raw excerpt stored.